Kazia Therapeutics Stock Forecast

Stock Price Forecast

According to 3 professional analysts, the 12-month price target for Kazia Therapeutics stock ranges from a low of $13 to a high of $20. The average analyst price target of $16 forecasts a 6.31% increase in the stock price over the next year.

Price Target: $16.00 (+6.31%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$13	$16	$15	$20
Change	-13.62%	+6.31%	-0.33%	+32.89%

* Price targets were last updated on Oct 2, 2025.

Analyst Ratings

The average analyst rating for Kazia Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jul '25	Aug '25	Sep '25	Oct '25	Nov '25	Dec '25
Strong Buy	2	2	2	3	3	3
Buy	0	0	0	0	0	0
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	2	2	2	3	3	3

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Naz Rahman Maxim Group	Maxim Group	Strong Buy Maintains $15 → $20	Strong Buy	Maintains	$15 → $20	+32.89%	Oct 2, 2025
Sean Lee HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $2 → $13	Strong Buy	Maintains	$2 → $13	-13.62%	Jul 10, 2025
Jason McCarthy Maxim Group	Maxim Group	Strong Buy Maintains $15	Strong Buy	Maintains	$15	-0.33%	Jun 11, 2025
Jason McCarthy Maxim Group	Maxim Group	Strong Buy Initiates $15	Strong Buy	Initiates	$15	-0.33%	Feb 6, 2025
Sean Lee HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $100	Strong Buy	Reiterates	$100	+564.45%	Jul 12, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

51.00K

from 1.83M

-97.21%

from 1.83M

Revenue Next Year

31.11K

from 51.00K

-39.00%

from 51.00K

EPS This Year

-1.20

from -18.89

EPS Next Year

-0.57

from -1.20

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Jun 30, 2021	Jun 30, 2022	Jun 30, 2023	Jun 30, 2024	Jun 30, 2025	Jun 30, 2026	Jun 30, 2027
Revenue	15.18M	10.00K	1,000.00	2.48M	1.83M	51.00K	31.11K
Revenue Growth	1,436.54%	-99.93%	-90.00%	248,000.00%	-26.28%	-97.21%	-39.00%
EPS	-35.80	-94.42	-55.53	-50.78	-18.89	-1.20	-0.57
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	4	4

Financial currency is AUD. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	105,000	64,050
Avg	51,000	31,110
Low	n/a	n/a

Revenue Growth

Revenue Growth	2026	2027
High	-94.3%	25.6%
Avg	-97.2%	-39.0%
Low	-	-

EPS Forecast

EPS	2026	2027
High	-1.05	-
Avg	-1.20	-0.57
Low	-1.32	-1.09

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.